61 related articles for article (PubMed ID: 22815318)
1. Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).
Rao VK; Price S; Perkins K; Aldridge P; Tretler J; Davis J; Dale JK; Gill F; Hartman KR; Stork LC; Gnarra DJ; Krishnamurti L; Newburger PE; Puck J; Fleisher T
Pediatr Blood Cancer; 2009 Jul; 52(7):847-52. PubMed ID: 19214977
[TBL] [Abstract][Full Text] [Related]
2. Dapsone for primary immune thrombocytopenia in adults and children: an evidence-based review.
Rodrigo C; Gooneratne L
J Thromb Haemost; 2013 Nov; 11(11):1946-53. PubMed ID: 23927583
[TBL] [Abstract][Full Text] [Related]
3. Dapsone for paediatric chronic immune thrombocytopenia: Short report from a tertiary centre in South India.
Bharadwaj N; Munireddy J; Selvam S; Bharadwaj V; Prakash A
Br J Haematol; 2024 Mar; 204(3):1024-1028. PubMed ID: 38220217
[TBL] [Abstract][Full Text] [Related]
4. Avatrombopag increased platelet count in a patient with chronic immune thrombocytopenia refractory to multiple lines of treatment.
Lebowa W; Zdziarska J; Sacha T
Blood Coagul Fibrinolysis; 2023 Jul; 34(5):327-332. PubMed ID: 37395226
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune Cytopenias Are Highly Associated with Inborn Errors of Immunity and They May Be the Initial Presentations in Cases without Severe Infections.
Taskin RB; Topyıldız E; Edeer Karaca N; Aksu G; Yılmaz Karapınar D; Kutukculer N
Int Arch Allergy Immunol; 2024; 185(4):392-401. PubMed ID: 38154455
[TBL] [Abstract][Full Text] [Related]
6. [Not Available].
Hbibi M; El Alaoui El Hanafi M; Kasmi Z; Ouair H; Benmiloud S; Ailal F; Hida M; Bousfiha AA
Tunis Med; 2024 Jan; 102(1):1-6. PubMed ID: 38545722
[TBL] [Abstract][Full Text] [Related]
7. Primary Evans syndrome in an adult man.
Makharia A; Lakhotia M; Roy B
BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34887288
[TBL] [Abstract][Full Text] [Related]
8. Paediatric-onset Evans syndrome: Breaking away from refractory immune thrombocytopenia.
Aladjidi N; Pincez T; Rieux-Laucat F; Nugent D
Br J Haematol; 2023 Oct; 203(1):28-35. PubMed ID: 37735545
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the prevalence of inborn errors of immunity in adults with chronic immune thrombocytopenia or Evans syndrome.
Jiang D; Rosenlind K; Baxter S; Gernsheimer T; Gulsuner S; Allenspach EJ; Keel SB
Blood Adv; 2023 Dec; 7(23):7202-7208. PubMed ID: 37792884
[TBL] [Abstract][Full Text] [Related]
10. Rituximab resistance in ITP and beyond.
Xiao Z; Murakhovskaya I
Front Immunol; 2023; 14():1215216. PubMed ID: 37575230
[TBL] [Abstract][Full Text] [Related]
11. T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome.
Kumar D; Prince C; Bennett CM; Briones M; Lucas L; Russell A; Patel K; Chonat S; Graciaa S; Edington H; White MH; Kobrynski L; Abdalgani M; Parikh S; Chandra S; Bleesing J; Marsh R; Park S; Waller EK; Prahalad S; Chandrakasan S
Blood; 2022 Jan; 139(3):369-383. PubMed ID: 34424963
[TBL] [Abstract][Full Text] [Related]
12. Response to rituximab in children and adults with immune thrombocytopenia (ITP).
Harris EM; Hillier K; Al-Samkari H; Berbert L; Grace RF
Res Pract Thromb Haemost; 2021 Aug; 5(6):e12587. PubMed ID: 34466770
[TBL] [Abstract][Full Text] [Related]
13. Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents.
Ollier N; Piel-Julian ML; Mahévas M; Viallard JF; Comont T; Chèze S; Audia S; Ebbo M; Terriou L; Lega JC; Jeandel PY; Bonnotte B; Michel M; Lapeyre-Mestre M; Godeau B; Moulis G
Blood; 2023 Sep; 142(12):1099-1101. PubMed ID: 37478400
[No Abstract] [Full Text] [Related]
14. Is There a Need to Look for Antithyroid Antibodies in Children With Immune Thrombocytopenia?
Lee AC
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1248. PubMed ID: 33512873
[No Abstract] [Full Text] [Related]
15. Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics.
Journeycake JM
Hematology Am Soc Hematol Educ Program; 2012; 2012():444-9. PubMed ID: 23233617
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of children with chronic immune thrombocytopenic purpura and Evans syndrome treated with rituximab.
Gokcebay DG; Tavil B; Fettah A; Yarali N; Azik FM; Tunc B
Clin Appl Thromb Hemost; 2013; 19(6):663-7. PubMed ID: 22815318
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficiency of rituximab therapy in children with chronic immune thrombocytopenic purpura.
Gurlek Gokcebay D; Guzelkucuk Z; Yarali N
Transfus Apher Sci; 2018 Jun; 57(3):416-417. PubMed ID: 29753699
[No Abstract] [Full Text] [Related]
18. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
